United States · Biotechnology Research
Research
Pharmaceuticals
Biotechnology
Healthcare
Biotechnology Research
Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.
2010
Founded
Biotechnology Research
Industry
United States
Location
281,367
Ranking
3,000 employees
Size

Get full access to view complete information
